Skip to main content
NCBI home page
Cell Cycle logoLink to Cell Cycle
. 2020 Apr 8;19(9):990–999. doi: 10.1080/15384101.2020.1743903

Overexpression of HIF-1α protects PC12 cells against OGD/R-evoked injury by reducing miR-134 expression

Hongliang Zhang a,*, Xianming Liu b,*, Fengyu Yang a, Dekui Cheng a, Wei Liu a,✉
PMCID: PMC7217352  PMID: 32266863

ABSTRACT

Nowadays, searching for new therapeutic targets for cerebral stroke treatment are still in urgent need. Our study explored the influences and mechanisms of HIF-1α on OGD/R-evoked injury. OGD/R treatment was conducted on PC12 cells to simulate ischemic injury. CCK-8, flow cytometry and qRT-PCR were conducted to determine the variations of cell viability, apoptosis and gene expression, respectively. Cell transfections were conducted to overexpress HIF-1α and miR-134. Variations of protein levels were evaluated by employing western blot. Results showed that OGD/R treatment induced cell injury through reducing viability, while enhancing apoptosis that was validated by the elevated ratios of C/P-PARP and C/P-caspase-3. HIF-1α expression was markedly increased by OGD/R treatment. HIF-1α overexpression attenuated OGD/R-evoked injury in PC12 cells and remarkably reversed OGD/R-triggered inhibitory effects on ERK1/2 and JAK1/STAT3 pathways. Besides, miR-134 was also down-regulated by HIF-1α overexpression in PC12 cells. Up-regulation of miR-134 notably counteracted HIF-1α overexpression-triggered neuro-protective impacts on OGD/R-evoked injury and ERK1/2 and JAK1/STAT3 pathways. Our present study reported that HIF-1α overexpression protected PC12 cells against OGD/R-evoked injury via down-regulation of miR-134, which making HIF-1α and miR-134 to be promising targets for cerebral stroke therapy.

KEYWORDS: Cerebral stroke, HIF-1α, miR-134, ERK1/2 and JAK1/STAT3 pathways

Introduction

Stroke is a major cause of disability and early adult death around the world [1]. Cerebral stroke is one of the acute cerebrovascular diseases [2]. Cerebral stroke includes hemorrhagic stroke and ischemic stroke, which is induced by vascular obstruction or blood vessels burst [3]. The incidence of ischemic stroke accounts for 60%–70% of the total cerebral stroke [4]. Cerebral stroke, which has the characteristics of high incidence, morbidity and disability, often results in brain tissue damage [5]. Numerous surviving stroke victims spend the rest of their lives in disability. Whereas, we have few effective therapies to improve the situation due to the poor understanding of the underlying mechanism of stroke-induced cell death. Therefore, finding effective therapies for cerebral stroke is urgently required.

Hypoxia-inducible factor-1 alpha (HIF-1α), a transcription factor, can regulate the expression of various genes that participating in the processes of angiogenesis, cellular survival and metabolism [6]. HIF-1α is also a pivotal regulator of hypoxia, which can regulate over 80 downstream genes to acclimatize cells to low oxygen condition [7]. In normoxia condition, HIF-1α expression is extremely low. However, under hypoxic condition, HIF-1α can’t be hydroxylated due to short of oxygen inactivating proline hydroxylase activity. Therefore, HIF-1α is stabilized in the cytoplasm and can be transported to the nucleus to regulate the expression of its target genes [8]. Growing studies have reported that HIF-1α played a vital role in cerebral ischemia. For instance, Shi reported the neuroprotective role of HIF-1α in cerebral ischemia [9]. Bok’s results showed that HIF-1α could increase the survival rate of neurons after ischemic stroke [10]. Another study disclosed that suppression of HIF-1α effectively alleviated ischemia/reperfusion-induced brain injury [11]. More importantly, oxygen-glucose deprivation (OGD)-induced cerebral injury is a frequently used model in the research on ischemic stroke in vitro [12,13]. However, factors regulating HIF-1α expression under OGD/R-induced injury remain to be further elucidated.

MicroRNAs (miRNAs) are a group of non-coding RNAs, which are responsible for the regulation of post-translational mRNA expression [14]. Several researches have indicated that miRNAs played crucial roles in cerebral ischemia [15]. Besides, previous investigations demonstrated that some of the miRNAs expression was associated with tissues oxygen levels and could be stimulated by hypoxia through regulating the expression of HIF-1 [16,17]. For instance, miR-107 expression was elucidated to be regulated by HIF-1α under hypoxic stress conditions, such as stroke and ischemic heart disease [18]. Besides, it was demonstrated that miR-200/PHD2/HIF-1α played a part in ischemic preconditioning [19]. miR-134 was previously documented to be highly expressed in the serum from patients with acute ischemic stroke [20]. Moreover, it was disclosed that inhibition of miR-134 could perform protective roles against ischemic/ischemic stroke-induced injury in N2A cells and mouse [21]. However, whether miR-134 participates in the regulation of HIF-1α in OGD/R-induced PC12 cells still remains largely unknown.

Previous investigations have indicated that the activation of ERK1/2 pathway was closely associated with the neuroprotective effects of drugs on ischemia/reperfusion-induced injury [22,23]. Besides, an earlier research recorded that epidermal growth factor (EGF) performed protective effects against cerebral ischemia/reperfusion-triggered injury through activation of JAK2/STAT3 pathway in rats [24]. Therefore, these results implicated that the activation of these two pathways were closely related to the protection of cells against is chemia/reperfusion-induced damage. However, whether these two pathways are involved in the function of HIF-1α and miR-134 in OGD/R-induced PC12 cells has not been investigated.

Here, OGD/R model was constructed in PC12 cells to explore the neuronprotective effects and mechanism of HIF-1α. Our data suggested that HIF-1α could protect PC12 cells against OGD/R-evoked injury through reducing miRNA-134 expression.

Materials and methods

Cell culture and OGD/R treatment

The PC12 cells (Cell Center of China Academy of Chinese Medical Sciences, Beijing, China) were incubated in Dulbecco’s Modified Eagle Medium (DMEM) (LifeTechnologies, Carlsbad, CA), replenished with 10% fetal bovine serum (FBS, BBI Solution, Crumlin, UK) and 1% GlutaMAX (Thermo Fisher Scientific, Massachusetts, USA) under 37°C and 5% CO2 conditions. Culture medium was refreshed every other day. Before OGD treatment, culture medium was refreshed with glucose-free DMEM, and then the cultured cells were put in an anaerobic chamber, filled with 95% N2 and 5% CO2 (v/v), and incubated at 37 ± 0.5°C. Afterward, the culture medium was substituted with normal medium for 2 h before accomplishing OGD treatment. Finally, cells were put back in the incubator and incubated for another 24 h. Cells incubated in normal medium and normoxia condition were served as control.

Cell counting kit-8 (CCK-8) assay

Cell viability was evaluated by employing CCK-8 assay (MedChemExpress, Shanghai, China). Firstly, cells were maintained in 96-well plate (5000 cells per well). After stimulation, CCK-8 reagent (10 μl) was supplied to each well, and the mixtures were maintained for another 1 h at 37°C. Finally, the absorbance at 450 nm was measured by using a Microplate Reader (Bio-Rad, Hercules, CA).

Apoptosis assay

Cell apoptosis was determined by utilizing Annexin V-fluorescein isothiocynate (FITC)/PI apoptosis detection kit (DOJINDO, Beijing, China). The cells were inoculated in 6-well plate (100,000 cells per well). After treatment, cells were rinsed twice with pre-cold (PBS) and then suspended in 1 × binding buffer. Then, Annexin V (5 μl) and PI (5 μl) were supplied to the suspended cells and maintained for 30 min at 25°C in dark. The flow cytometer (Beckman Coulter, Brea, CA, USA) was employed for differing apoptotic cells and necrotic cells. Data were analyzed utilizing FlowJo software (Tree Star Inc., Ashland, OR, USA).

Western blot

Proteins were extracted from cells by utilizing RIPA lysis buffer (Beyotime Biotechnology, Shanghai, China). Quantification of extracted proteins was conducted by utilizing the BCA Protein Assay Kit (Solarbio, Beijing, China). Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was employed for separating the target proteins, and then the separated proteins were transferred onto PVDF membranes (Millipore Corporation, Billerica, MA, USA). Primary antibodies were blocked in 5% bovine serum albumin (BSA, BBI Solution, Crumlin, UK). After washing, the membranes were maintained with primary antibodies against PARP (ab227244, Abcam, Cambridge, UK), Cleaved-PARP (ab32064, Abcam), Pro-caspase-3 (ab90437, Abcam), Cleaved-caspase-3 (ab13847, Abcam), HIF-1α (ab216842, Abcam), t-ERK1/2 (ab196883, Abcam), p-ERK1/2 (4370, Cell Signaling Technology, Massachusetts, USA), t-JAK1 (ab125051, Abcam), p-JAK1 (3344, Cell Signaling Technology), t-STAT3 (ab109085, Abcam), p-STAT3 (ab30647, Abcam), β-actin (ab119716, Acam) at 4°C for 16 h, and then incubated with secondary antibody (ab97200, Abcam) at 25°C for 1 hour. The protein bands were visualized by utilizing a chemilumin-escence detection system (Amersham, Little Chalfont, UK).

Cell transfection

Cell transfection was performed when cells were in 70–80% of confluency. The full-length HIF-1α sequence was linked into the pcDNA3.1 vector and referred as pc-HIF-1α. Afterward, cell transfection was performed utilizing the lipofectamine3000 reagent (Thermo Fisher Scientific, Massachusetts, USA) according to the product instructions. MiR-134 mimic and negative control (NC) mimic were synthesized by Life Technologies Corporation (MD, USA) and were respectively transfected into cells. The doses of pc-HIF-1α vector, miR-134 mimic and their corresponding controls were respectively 1 μg and 100 nM. Finally, the harvest time was set at 48 h after transfection.

Quantitative reverse-transcription polymerase chain reaction (qRT-PCR)

The total cellular RNA was isolated from transfected cells by means of TRIzol reagent (Invitrogen) with the existence of DNaseI (Promega). Afterward, Mult-iscribe RT kit (Applied Biosystems, Massachusetts, USA) was employed for fulfilling reverse transcription reaction. The reverse transcription was accomplished with the following conditions: 25°C (10 min), 48°C (30 min), and a final step of 95°C (5 min). The primer sequences were displayed as below: miR-134: Forward 5'-ACACTCCAGCTGGGCCTGTGGGCCACCTAGT-3', Reverse 5'-TGGTGTCGTGGAGTCG-3'; U6: Forward: 5'-CTCGCTTCGGCAGCACA-3', Reverse: 5'-AACGCTTCACGAATTTGCGT-3'.

Statistical analysis

The quantitative data were expressed as mean ± standard deviation (SD). Statistical analysis was accomplished by employing SPSS 19.0 statistical software (SPSS, Inc., Chicago, IL, USA). The P-values were figured out by utilizing a one-way analysis of variance (ANOVA) or Student’s t-test. Differences with a P value less than 0.05 were regarded as statistically significant.

Results

OGD/R treatment  induced apoptosis in PC12 cells

First of all, we determined the influences of OGD/R on PC12 cells. As displayed in Figure 1(a,b), OGD/R treatment prominently reduced viability while notably promoted apoptosis of PC12 cells (P < 0.01, P < 0.001). Besides, outcomes of western blot revealed that OGD/R treatment observably up-regulated the ratios of apoptosis-related C/P-PARP and C/P-caspase-3 relative to control (Figure 1(c,d), both P < 0.001). These observations illustrated that OGD/R treatment triggered cell injury in PC12 cells through inhibiting cell viability while promoting apoptosis.

Figure 1.

Figure 1.

Open in a new tab

OGD/R induced apoptosis of PC12 cells. (a). Cell viability was detected by CCK-8 assay. (b). Flow cytometry was employed for analysis of cell apoptosis. (c-d). Relative expression of apoptosis-related proteins (PARP, Cleaved-PARP, Pro-caspase-3 and Cleaved-caspase-3) was examined using western blot. **P < 0.01, ***P < 0.001.

OGD/R treatment up-regulated HIF-1α expression

Then we tested HIF-1α expression in OGD/R-triggered PC12 cells. Western blot results suggested that HIF-1α expression was remarkably elevated by OGD/R treatment (Figure 2(a,b), P < 0.001). These outcomes indicated that OGD/R treatment effectively up-regulated HIF-1α expression in PC12 cells.

Figure 2.

Figure 2.

Open in a new tab

OGD/R treatment up-regulated HIF-1α expression in PC12 cells. (a-b). Relative expression of HIF-1α was determined by using western blot. ***P < 0.001.

HIF-1α overexpression relieved OGD/R-evoked injury

HIF-1α overexpression was conducted in PC12 cells by using cell transfection and the transfection efficiency was subsequently determined by employing western blot. The results suggested that HIF-1α expression was pronouncedly overexpressed (Figure 3(a,b), P < 0.001). Besides, results of CCK-8 assay and flow cytometry analysis revealed that HIF-1α overexpression prominently ameliorated OGD/R-evoked cell injury exhibiting as observably upgraded cell viability and notably repressed apoptosis in PC12 cells compared with cells transfected with pc-DNA3.1 (Figure 3(c,d), both P < 0.05). Furthermore, the OGD/R-triggered elevated ratios of C/P-PARP and C/P-caspase-3 were prominently decreased by HIF-1α overexpression (Figure 3(e,f), both P < 0.01). These observations hinted that HIF-1α overexpression could alleviate OGD/R-evoked injury in PC12 cells.

Figure 3.

Figure 3.

Open in a new tab

Overexpression of HIF-1α relieved OGD/R-evoked cell injury in PC12 cells. (a-b). Relative expression of HIF-1α was examined by using western blot. (c). CCK-8 assay was employed for determining cell viability. (d). Cell apoptosis was analyzed by employing flow cytometry. E-F. Relative expression of PARP, Cleaved-PARP, Pro-caspase-3 and Cleaved-caspase-3 was determined by using western blot. *P < 0.05, **P < 0.01, ***P < 0.001.

HIF-1α overexpression suppressed miR-134 expression

qRT-PCR analysis revealed that miR-134 expression was significantly declined by HIF-1α overexpression relative to pcDNA3.1 transfected group (Figure 4(a), P < 0.05). Besides, following experiments showed that miR-134 expression was notably enhanced by OGD/R treatment relative to control (P < 0.05). However, miR-134 expression was remarkably reduced by HIF-1α overexpression compared with cells transfected with pcDNA3.1 (Figure 4(b), P < 0.01). Our results elucidated that HIF-1α overexpression might relieve OGD/R-induced injury through suppressing miR-134 expression in PC12 cells.

Figure 4.

Figure 4.

Open in a new tab

Overexpression of HIF-1α suppressed miR-134 expression in PC12 cells. (a). qRT-PCR was utilized for the detection of miR-134 expression in HIF-1α overexpressed PC12 cells. (b). qRT-PCR was utilized for the detection of miR-134 expression in OGD/R-induced and HIF-1α-overexpressed PC12 cells. *P < 0.05, **P < 0.01.

HIF-1α overexpression relieved OGD/R-evoked injury through reducing miR-134 expression

As HIF-1α overexpression could suppress miR-134 expression in PC12 cells, we came up with the hypothesis that HIF-1α may protect PC12 cells against OGD/R-evoked cell injury by reducing miR-134 expression. To verify this hypothesis, up-regulation of miR-134 was conducted in PC12 cells by using cell transfection, and the transfection efficiency was tested by utilizing qRT-PCR. The outcomes turned out to be that miR-134 expression was remarkably up-graded in PC12 cells (Figure 5(a), P < 0.01). Besides, we observed that miR-134 up-regulation dramatically counteracted HIF-1α overexpression-triggered effects on cell viability, cell apoptosis, as well as on the ratios of apoptosis-related C/P-PARP and C/P-caspase-3 relative to pc-HIF-1α + NC mimic transfected group (Figure 5(b–e), P < 0.05, P < 0.01). The above observations led to a conclusion demonstrating that HIF-1α overexpression relieved OGD/R-evoked cell injury through repressing miR-134 expression in PC12 cells.

Figure 5.

Figure 5.

Open in a new tab

HIF-1α overexpression relieved cell injury by reducing miR-134 expression in PC12 cells. (a). qRT-PCR was utilized for the detection of miR-134 expression. (b). CCK-8 assay was used for the detection of cell viability. (c). Flow cytometry was employed for analysis of cell apoptosis. (d-e). Western blot was employed for the detection of the expression of apoptosis-related PARP, Cleaved-PARP, Pro-caspase-3 and Cleaved-caspase-3. *P < 0.05, **P < 0.01, ***P < 0.001.

HIF-1α activated ERK1/2 and JAK1/STAT3 pathways through suppressing miR-134 expression

For determining the underlying mechanisms of how HIF-1α overexpression attenuated OGD/R-evoked cell injury, the expression of pivotal proteins participated in ERK1/2 and JAK1/STAT3 pathways were examined. Western blot analysis revealed that OGD/R treatment pronouncedly decreased the ratios of p/t-ERK1/2, p/t-JAK1 and p/t-STAT3 (P < 0.05 or P < 0.01), while HIF-1α overexpression partially mitigated or even totally reversed these effects (Figure 6(a–d), P < 0.05 or P < 0.001). Furthermore, miR-134 up-regulation prominently eliminated HIF-1α overexpression-triggered effects (Figure 6(a–d), P < 0.05 or P < 0.001). A conclusion can be draw from the above observations demonstrating that HIF-1α overexpression activated ERK1/2 and JAK1/STAT3 pathways through suppressing miR-134 expression in PC12 cells.

Figure 6.

Figure 6.

Open in a new tab

HIF-1α overexpression activated ERK1/2 and JAK1/STAT3 pathways by decreasing miR-134 expression. (a-d). The expression of t-ERK1/2, p-ERK1/2, t-JAK1, p-JAK1, t-STAT3 and p-STAT3 were determined by employing western blot. *P < 0.05, **P < 0.01, ***P < 0.001.

Discussion

Cerebral stroke is a main reason for death in the elderly population and researches on this have important clinical implications. Therefore, finding novel drug targets of stroke is quite important for the management. Previous researches have indicated that HIF-1α played a vital role in cerebral ischemia. Here, we found out that HIF-1α overexpression could alleviate OGD/R-evoked cell injury through reducing miR-134 expression, which making it a promising therapeutic target for cerebral stroke therapy.

OGD/R-induced cell damage was often used in studies to serve as a model of stroke in vitro [25,26]. Our present study found out that OGD/R treatment triggered cell injury via suppressing the viability and increasing apoptosis of PC12 cells. Besides that, expression of apoptosis-related proteins Cleaved-caspase-3 and Cleaved-PARP were also enhanced by OGD/R treatment. Similarly, Dorfman et al. reported that OGD/R could induce neuronal damage in PC12 cells [26]. Cao and his colleagues also reported that OGD treatment decreased cell viability and accelerated apoptosis in PC12 cells [13].

HIF-1 is a crucial nuclear transcription factor in the process of acclimatizing to hypoxia condition [27,28]. HIF-1α would be degraded by proteasomes under normoxic conditions. However, HIF-1α would be transferred into the nucleus and bind to HIF-1β to form HIF-1, which would subsequently initiate or promote transcription of effector genes under hypoxia conditions [29,30]. As the main transcription factor of hypoxia, HIF-1α has been extensively studied in cerebral ischemia, and the neuro-protective effects of HIF-1α have also been elucidated in various studies. For instance, Liu’s research revealed that induction of HIF-1α led to activation of PI3K/AKT/mTOR pathway, which could facilitate the anti-apoptotic effects of Catalpol and Peurarin against cerebral ischemia [31]. Moreover, Cao and his colleagues indicated that suppression of HIF-1α-facilitated OGD-induced cell damage in PC12 cells [13]. The same results were also found in our research demonstrating that HIF-1α level was elevated by OGD/R treatment. Overexpression of HIF-1α was found to alleviate OGD/R-evoked cell injury through upgrading cell viability and reducing apoptosis. These outcomes hinted that HIF-1α could be a possible therapeutic target for cerebral stroke.

miRNAs, a group of endogenous single stranded and non-coding RNA molecules (21–22 nt), are responsible for the regulation of post-translational mRNA expression [14]. Recently, a growing number of researches have pointed out that miRNAs took crucial part in the regulation of neuronal cell death, which is important in the stroke pathophysiology process [32]. Study performed by Zhu et al. revealed that inhibiting miR-124 expression significantly decreased neuron death and mitigated ischemia/reperfusion-induced brain injury and dysfunction through regulating Ku70 expression [33]. Peng et al. also suggested that down-regulation of miR-181b reduced ischemic neuronal death through regulating HSPA5 and UCHL1 protein levels [34]. MiR-134 is the first identified dendritic miRNA which can regulate a series of progresses including synaptic development, maturation, and plasticity, which were associated with the morphology of dendritic spine [35]. The roles of miR-134 have been investigated in numbers of neurological disorders. For instance, a previous literature reported that down-regulation of miR-134 alleviated ischemic injuries by promoting the expression of CREB and the downstream genes [36]. Another research discovered that down-regulation of miR-134 protected neural cells against ischemic injury both in vivo and in vitro by negatively up-regulating HSPA12B [21]. Therefore, inhibiting the expression of miR-134 might exert neuron-protective effects. Similarly, in this investigation, we observed that OGD/R treatment elevated miR-134 expression, while HIF-1α overexpression decreased miR-134 expression in PC12 cells, indicating that HIF-1α overexpression might ameliorate OGD/R-evoked cell injury via reducing miR-134 expression. Following results showed that up-regulation of miR-134 counteracted HIF-1α overexpression-triggered neuro-protective effects on OGD/R-evoked PC12 cells. From the above outcomes, we came to a conclusion demonstrating that HIF-1α overexpression protected PC12 cells against OGD/R-evoked injury through reducing miR-134 expression.

Activation of ERK1/2 pathway is reported to take an important part in several models of neuronal death [37]. Phosphorylation of ERK after ischemia has been suggested to support neuronal survival [38]. Besides, evidences also showed that ERK1/2 and JAK/STAT3 pathways participated in pro-angiogenesis after stroke [39,40]. JAK1/STAT3 pathway was reported to participate in neuronal apoptosis in a rat model of neuronal hypoxic-ischemic encephalopathy[41]. Our results went in line with these earlier investigations. In this investigation, we figured out that OGD/R treatment suppressed ERK1/2 and JAK1/STAT3 pathways, while HIF-1α overexpression had the opposite effects. MiR-134 up-regulation counteracted HIF-1α overexpression-triggered promoting effects on ERK1/2 and JAK1/STAT3 pathways. Thus, we concluded that HIF-1α overexpression activated ERK1/2 and JAK1/STAT3 pathways through decreasing the expression of miR-134 in PC12 cells.

In conclusion, our present study reported that HIF-1α overexpression protected PC12 cells against OGD/R-evoked cell injury through decreasing miR-134 expression and thereby activating ERK1/2 and JAK1/STAT3 pathways. These findings make HIF-1α and miR-134 promising targets for cerebral stroke treatment.

Funding Statement

This work was supported by the Shandong Natural Science Foundation [ZR2016HB64] and the Funding of Applied Research Project for postdoctoral researchers in Qingdao [40518060079].

Disclosure statement

No potential conflict of interest was reported by the authors.

Data availability statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  • [1].Donnan GA, Fisher M, Macleod M, et al. Stroke. Lancet 2008; 371:1612–1623. [DOI] [PubMed] [Google Scholar]
  • [2].Aries MJ, Elting JW, De Keyser J, et al. Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke 2010; 41:2697–2704. [DOI] [PubMed] [Google Scholar]
  • [3].Stevenson SF, Doubal FN, Shuler K, et al. A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 2010; 41:e434–42. [DOI] [PubMed] [Google Scholar]
  • [4].Siniscalchi A, Gallelli L, Malferrari G, et al. Cerebral stroke injury: the role of cytokines and brain inflammation. J Basic Clin Physiol Pharmacol 2014; 25:131–137. [DOI] [PubMed] [Google Scholar]
  • [5].Menon BK, Campbell BC, Levi C, et al. Role of imaging in current acute ischemic stroke workflow for endovascular therapy. Stroke 2015; 46:1453–1461. [DOI] [PubMed] [Google Scholar]
  • [6].Semenza GL Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3:721–732. [DOI] [PubMed] [Google Scholar]
  • [7].Benita Y, Kikuchi H, Smith AD, et al. An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 2009; 37:4587–4602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Wenger RH Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002; 16:1151–1162. [DOI] [PubMed] [Google Scholar]
  • [9].Shi H Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr Med Chem 2009; 16:4593–4600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Bok S, Kim YE, Woo Y, et al. Hypoxia-inducible factor-1alpha regulates microglial functions affecting neuronal survival in the acute phase of ischemic stroke in mice. Oncotarget 2017; 8:111508–111521.. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Chen C, Hu Q, Yan J, et al.Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis 2009; 33:509–517. [DOI] [PubMed] [Google Scholar]
  • [12].Zhao J, Li L, Ling C, et al.Marine compound Xyloketal B protects PC12 cells against OGD-induced cell damage. Brain Res 2009; 1302:240–247. [DOI] [PubMed] [Google Scholar]
  • [13].Cao YX, Wang ZQ, Kang JX, et al. miR-424 protects PC-12 cells from OGD-induced injury by negatively regulating MKP-1. Eur Rev Med Pharmacol Sci 2018; 22:1426–1436. [DOI] [PubMed] [Google Scholar]
  • [14].Dykstra-Aiello C, Jickling GC, Ander BP, et al. Altered expression of long noncoding RNAs in blood after ischemic stroke and proximity to putative stroke risk loci. Stroke 2016; 47:2896–2903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Liu P, Zhao H, Wang R, et al.MicroRNA-424 protects against focal cerebral ischemia and reperfusion injury in mice by suppressing oxidative stress. Stroke 2015; 46:513–519. [DOI] [PubMed] [Google Scholar]
  • [16].Wang F, Xiong L, Huang X, et al.miR-210 suppresses BNIP3 to protect against the apoptosis of neural progenitor cells. Stem Cell Res 2013; 11:657–667. [DOI] [PubMed] [Google Scholar]
  • [17].Czyzyk-Krzeska MF, Zhang X. MiR-155 at the heart of oncogenic pathways. Oncogene 2014; 33:677–678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Chen Z, Lai TC, Jan YH, et al.Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis. J Clin Invest 2013; 123:1057–1067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Lee ST, Chu K, Jung KH, et al.MicroRNAs induced during ischemic preconditioning. Stroke 2010; 41:1646–1651. [DOI] [PubMed] [Google Scholar]
  • [20].Zhou J, Chen L, Chen B, et al. Increased serum exosomal miR-134 expression in the acute ischemic stroke patients. BMC Neurol. 2018; 18:198.. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Chi W, Meng F, Li Y, et al. Downregulation of miRNA-134 protects neural cells against ischemic injury in N2A cells and mouse brain with ischemic stroke by targeting HSPA12B. Neuroscience 2014; 277:111–122. [DOI] [PubMed] [Google Scholar]
  • [22].Yu Z, Cai M, Li X, et al.Neuroprotective effects of Tongxinluo on focal cerebral ischemia and reperfusion injury in rats associated with the activation of the MEK1/2/ERK1/2/p90RSK signaling pathway. Brain Res 2018; 1685:9–18. [DOI] [PubMed] [Google Scholar]
  • [23].Liu XY, Zhou XY, Hou JC, et al. Ginsenoside Rd promotes neurogenesis in rat brain after transient focal cerebral ischemia via activation of PI3K/Akt pathway. Acta Pharmacol Sin 2015; 36:421–428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Tang Y, Tong X, Li Y, et al. JAK2/STAT3 pathway is involved in the protective effects of epidermal growth factor receptor activation against cerebral ischemia/reperfusion injury in rats. Neurosci Lett 2018; 662:219–226. [DOI] [PubMed] [Google Scholar]
  • [25].Mo ZT, Fang YQ, He YP, et al. beta-Asarone protects PC12 cells against OGD/R-induced injury via attenuating Beclin-1-dependent autophagy. Acta Pharmacol Sin 2012; 33:737–742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Dorfman K, Carrasco D, Gruda M, et al. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene 1996; 13:925–931. [PubMed] [Google Scholar]
  • [27].Loboda A, Jozkowicz A, Dulak J. HIF-1 versus HIF-2–is one more important than the other? Vascul Pharmacol 2012; 56:245–251. [DOI] [PubMed] [Google Scholar]
  • [28].Semenza GL Molecular mechanisms mediating metastasis of hypoxic breast cancer cells. Trends Mol Med 2012; 18:534–543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Chu HX, Jones NM. Changes in Hypoxia-Inducible Factor-1 (HIF-1) and Regulatory Prolyl Hydroxylase (PHD) enzymes following hypoxic-ischemic injury in the neonatal rat. Neurochem Res 2016; 41:515–522. [DOI] [PubMed] [Google Scholar]
  • [30].Xiong X, Fu M, Lan D, et al. Yak response to high-altitude hypoxic stress by altering mRNA expression and DNA methylation of hypoxia-inducible factors. Anim Biotechnol 2015; 26:222–229 [DOI] [PubMed] [Google Scholar]
  • [31].Liu Y, Tang Q, Shao S, et al. Lyophilized powder of catalpol and puerarin protected cerebral vessels from ischemia by its anti-apoptosis on endothelial cells. Int J Biol Sci 2017; 13:327–338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Barca-Mayo O, De Pietri Tonelli D.. Convergent microRNA actions coordinate neocortical development. Cell Mol Life Sci 2014; 71:2975–2995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Zhu F, Liu JL, Li JP, et al. MicroRNA-124 (miR-124) regulates Ku70 expression and is correlated with neuronal death induced by ischemia/reperfusion. J Mol Neurosci 2014; 52:148–155. [DOI] [PubMed] [Google Scholar]
  • [34].Peng Z, Li J, Li Y, et al. Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1. J Neurosci Res 2013; 91:1349–1362. [DOI] [PubMed] [Google Scholar]
  • [35].Schratt GM, Tuebing F, Nigh EA, et al. A brain-specific microRNA regulates dendritic spine development. Nature 2006; 439:283–289. [DOI] [PubMed] [Google Scholar]
  • [36].Huang W, Liu X, Cao J, et al. miR-134 regulates ischemia/reperfusion injury-induced neuronal cell death by regulating CREB signaling. J Mol Neurosci 2015; 55:821–829. [DOI] [PubMed] [Google Scholar]
  • [37].Subramaniam S, Unsicker K. ERK and cell death: ERK1/2 in neuronal death. Febs J 2010; 277:22–29. [DOI] [PubMed] [Google Scholar]
  • [38].Wortzel I, Seger R. The ERK cascade: distinct functions within various subcellular organelles. Genes Cancer 2011; 2:195–209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Dong W, Xian Y, Yuan W, et al.Catalpol stimulates VEGF production via the JAK2/STAT3 pathway to improve angiogenesis in rats’ stroke model. J Ethnopharmacol 2016; 191:169–179. [DOI] [PubMed] [Google Scholar]
  • [40].Slevin M, Krupinski J, Slowik A, et al. Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. Neuroreport 2000; 11:2759–2764. [DOI] [PubMed] [Google Scholar]
  • [41].Dixon BJ, Chen D, Zhang Y, et al. Intranasal administration of interferon beta attenuates neuronal apoptosis via the JAK1/STAT3/BCL-2 pathway in a rat model of neonatal hypoxic-ischemic encephalopathy. ASN Neuro 2016; 8:1759091416670492. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Articles from Cell Cycle are provided here courtesy of Taylor & Francis

RESOURCES